Goodpoint Chemicals OÜ is implementing its development plan within the framework of the Corporate Development Program support measure. The aim of the project is to strengthen the innovation and development capabilities of Goodpoint Chemicals OÜ, expand the product portfolio with new research- and evidence-based health technology products, and increase the company’s export revenues. As a result of the project, we want to improve the company’s financial results, streamline production processes, and bring products with higher added value to the market.
The project is supported by the EIF, the eligible period for the project is 01.12.2025–31.05.2027.
The total investment volume of the project is 496,971 euros, of which the support from the European Regional Development Fund is up to 223,636.95 euros.
